Antitumor activity of humanized monoclonal antibody against HM1.24 antigen in human myeloma xenograft models

Oncology Reports

Volumn 15, Issue 2, 2006, Pages 361-367

  Kawai, Shigeto ^a   Yoshimura, Yasushi ^a   Iida, Shin Ichiro ^a   Kinoshita, Yasuko ^a   Koishihara, Yasuo ^a   Ozaki, Shuji ^b   Matsumoto, Toshio ^b   Kosaka, Masaaki ^c   Yamada Okabe, Hisafumi ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^b TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

^c Tokushima Red Cross Blood Center   (Japan)

Author keywords

Antibody dependent cellular cytotoxicity; ARH 77; HM1.24; Humanized antibody; KPMM2; Multiple myeloma; RPMI 8226; Xenograft model

Indexed keywords

BST2 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY;

ANIMAL; ANTIBODY AFFINITY; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY SPECIFICITY; ARTICLE; DRUG SCREENING; EPITOPE MAPPING; FLOW CYTOMETRY; HUMAN; IMMUNOLOGY; MALE; MONONUCLEAR CELL; MOUSE; MOUSE MUTANT; MULTIPLE MYELOMA; NATURAL KILLER CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, CD; EPITOPE MAPPING; FLOW CYTOMETRY; HUMANS; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, SCID; MULTIPLE MYELOMA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33744496095     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.2.361     Document Type: Article

References (13)

1. Kyle RA: Multiple myeloma: review of 869 cases. Mayo Clin Proc 50: 29-40, 1975.
2. Klein B: Cytokine, cytokine receptors, transduction signals and oncogenes in human multiple myeloma. Semin Hematol 32: 4-19, 1995.
3. Kyle RA and Rajkumar SV: Multiple myeloma. N Engl J Med 351: 1860-1873, 2004.
4. Barlogie B, Shaughnessy J, Tricot G, et al : Treatment of multiple myeloma. Blood 103: 20-32, 2004. (Pubitemid 38029914)
5. Hideshima T, Bergsagel PL, Kuehl WM and Anderson KC: Advances in biology of multiple myeloma: clinical applications. Blood 104: 607-618, 2004. (Pubitemid 38970551)
6. Ohtomo T, Sugamata Y, Ozaki Y, et al: Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells. Biochem Biophys Res Commun 258: 583-591, 1999. (Pubitemid 29290312)
7. Goto T, Kennel SJ, Abe M, et al: A novel membrane antigen selectively expressed on terminally differentiated human B cells. Blood 84: 1922-1930, 1994. (Pubitemid 24286144)
8. Ozaki S, Kosaka M, Wakatsuki S, Abe M, Koishihara Y and Matsumoto T: Immunotherapy of multiple myeloma with a monoclonal antibody directed against a plasma cell-specific antigen, HM1.24. Blood 90: 3179-3186, 1997. (Pubitemid 27444214)
9. Ono K, Ohtomo T, Yoshida K, et al: The humanized anti-HM1.24 antibody effectively kills multiple myeloma cells by human effector cell-mediated cytotoxicity. Mol Immunol 36: 387-395, 1999. (Pubitemid 29331647)
10. Ozaki S, Kosaka M, Wakahara Y, et al: Humanized anti-HM1.24 antibody mediates myeloma cell cytotoxicity that is enhanced by cytokine stimulation of effector cells. Blood 93: 3922-3930, 1999. (Pubitemid 29249841)
11. Tejedor F and Hunter JPG: Iodination of biological samples without loss of functional activity. Anal Biochem 127: 143-149, 1975.
12. Goto H, Shimazaki C, Tatsumi T, et al : Establishment of a novel myeloma cell line KPMM2 carrying t(3;14)(q21;q32), which proliferates specifically in response to interleukin-6 through an autocrine mechanism. Leukemia 9: 711-718, 1995.
13. Tsunenari T, Koishihara Y, Nakamura A, et al: New xenograft model of multiple myeloma and efficacy of a humanized antibody against human interleukin-6 receptor. Blood 90: 2437-2444, 1997. (Pubitemid 27392728)